DK1040107T3 - 6-O-alkyl-derivater af erythronolid B - Google Patents

6-O-alkyl-derivater af erythronolid B

Info

Publication number
DK1040107T3
DK1040107T3 DK98959480T DK98959480T DK1040107T3 DK 1040107 T3 DK1040107 T3 DK 1040107T3 DK 98959480 T DK98959480 T DK 98959480T DK 98959480 T DK98959480 T DK 98959480T DK 1040107 T3 DK1040107 T3 DK 1040107T3
Authority
DK
Denmark
Prior art keywords
erythronolide
alkyl derivatives
erythromycin
novel
derivatives
Prior art date
Application number
DK98959480T
Other languages
English (en)
Inventor
Howard E Gracey
Stephen H Montgomery
David A Riley
Jih-Hua Liu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1040107T3 publication Critical patent/DK1040107T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
DK98959480T 1997-12-01 1998-11-17 6-O-alkyl-derivater af erythronolid B DK1040107T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/980,919 US5919916A (en) 1997-12-01 1997-12-01 6-O-alkyl derivatives of erythronolide B
PCT/US1998/024497 WO1999028311A1 (en) 1997-12-01 1998-11-17 6-o-alkyl derivatives of erythronolide b

Publications (1)

Publication Number Publication Date
DK1040107T3 true DK1040107T3 (da) 2003-05-05

Family

ID=25527957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98959480T DK1040107T3 (da) 1997-12-01 1998-11-17 6-O-alkyl-derivater af erythronolid B

Country Status (13)

Country Link
US (1) US5919916A (da)
EP (1) EP1040107B1 (da)
JP (1) JP2001524549A (da)
KR (1) KR20010032636A (da)
AT (1) ATE231851T1 (da)
AU (1) AU1526899A (da)
CA (1) CA2309977A1 (da)
DE (1) DE69811120T2 (da)
DK (1) DK1040107T3 (da)
ES (1) ES2191982T3 (da)
IL (1) IL135792A0 (da)
PT (1) PT1040107E (da)
WO (1) WO1999028311A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
RU2230748C2 (ru) * 2000-03-15 2004-06-20 Ханми Фарм. Ко., Лтд. Способ получения кларитромицина в виде кристаллов формы ii
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 a의 제조방법
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6455680B1 (en) 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives
TWI246515B (en) 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
US7825200B2 (en) * 2003-02-28 2010-11-02 The Regents Of The University Of California Controlled free radical grafting from polyolefins
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697547A (en) * 1970-12-18 1972-10-10 Abbott Lab Erythronolide b derivatives
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンb誘導体
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−n−メチルエリスロマイシン誘導体
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH08149986A (ja) * 1994-09-28 1996-06-11 Taisho Pharmaceut Co Ltd 12−ヒドロキシ−6−o−アルキルエリスロマイシン及びその類縁体の製造方法
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making

Also Published As

Publication number Publication date
EP1040107A1 (en) 2000-10-04
AU1526899A (en) 1999-06-16
CA2309977A1 (en) 1999-06-10
JP2001524549A (ja) 2001-12-04
WO1999028311A1 (en) 1999-06-10
ES2191982T3 (es) 2003-09-16
US5919916A (en) 1999-07-06
KR20010032636A (ko) 2001-04-25
PT1040107E (pt) 2003-06-30
DE69811120D1 (de) 2003-03-06
DE69811120T2 (de) 2003-10-09
ATE231851T1 (de) 2003-02-15
IL135792A0 (en) 2001-05-20
EP1040107B1 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
DK1040107T3 (da) 6-O-alkyl-derivater af erythronolid B
ATE256138T1 (de) 9-oximsilyl erythromycin a derivate
FI931109L (fi) Peptider och nukleinsyrasekvenser, som haenfoer sig till epstein-barr-virus
DK1015466T3 (da) Derivater af 9-hydrazon og 9-azinerythromycin og en fremgangsmåde til fremstilling af samme
NO904839D0 (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
FI971609L (fi) Menetelmä 4a,5,9,10,11,12-heksahydro-6H-bentsofuro-(3a,3,2-ef)(2)-bentsatsepiinijohdannaisten valmistamiseksi
FI20040310A7 (fi) Menetelmä bentsosykloalkyyliatsolitionijohdannaisten valmistamiseksi
DK90393D0 (da) Fremgangsmaade til fremstilling af macrolidforbindelser
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0451094T3 (da) Fremgangsmåde til fremstilling af pigmenter
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
NO901070D0 (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK603088D0 (da) Fremgangsmaade til fremstilling af multiglucosylforgrenede cyclodextriner
DK0749947T4 (da) Kontinuerlig fremgangsmåde til fremstilling af natrium-C(4-8)alkoxid
PT88158A (pt) Process for the preparation of a novel diosmin derivative
IS1853B (is) Ný aðferð til að búa til 3-N,N-dísýklóbútýlamínó-8-flúor-3,4-díhýdró-2H-1-bensópýran-5-karboxamíð
FI872073A0 (fi) Derivat av propargyloxybenzener, deras framstaellning och fungicida sammansaettningar i vilka de ingaor.
DK0729971T3 (da) Fremgangsmåde til fremstilling af ivermectin
ES2079569T3 (es) Calicheamicinona, sus derivados y analogos y procedimientos de fabricacion de los mismos.
DK1080076T3 (da) Forbedret fremgangsmåde til fremstilling af farmaceutisk værdifulde norbenzomorphanderivater
DK162191D0 (da) Fremgangsmaade til fremstilling af prolinderivat
DK587287D0 (da) Fremgangsmaade til fremstilling af 2-guanidinotiazolderivater
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid